SML2364

4-Androstenedione

≥98% (HPLC)

• Synonym(s): 4-Androstene-3,17-dione, (8R,9S,10R,13S,14S)-10,13-dimethyl-1,6,7,8,9,10,11,12,13,14,15,16-dodecahydro-3H-cyclopenta[a]phenanthrene-3,17(2H)-dione, 17-Ketotestosterone, 3,17-Dioxoandrost-4-ene, Androst-4-ene-3,17-dione, Androstenedione, Fecundin, NSC 9563, SKF 2170
• Empirical Formula (Hill Notation): C₁₉H₂₆O₂
• CAS Number: 63-05-8
• Molecular Weight: 286.41
• Beilstein: 2059239
• MDL number: MFCD00003615
• UNSPSC Code: 12352200
• NACRES: NA.77

Properties

• Quality Level: 100
• Assay: ≥98% (HPLC)
• form: powder
• drug control: USDEA Schedule III
• color: white to beige
• solubility: DMSO: 2 mg/mL, clear
• storage temp.: room temp
• SMILES string: [H][C@@]12CCC3=CC(=O)CC[C@]3(C)[C@@]1([H])CC[C@]4(C)C(=O)CC[C@@]24[H]
• InChI: 1S/C19H26O2/c1-18-9-7-13(20)11-12(18)3-4-14-15-5-6-17(21)19(15,2)10-8-16(14)18/h11,14-16H,3-10H2,1-2H3/t14-,15-,16-,18-,19-/m0/s1
• InChI key: AEMFNILZOJDQLW-QAGGRKNESA-N

Description

Biochem/physiol Actions

4-Androstenedione, commonly known as Androstenedione, is an endogenous androgen steroid hormone. 4-Androstenedione functions as an intermediate in the biosynthesis of testosterone, estradiol and estrone. Recent studies indicate that 4-Androstenedione is involved in aromatase inhibitors induce painful musculoskeletal symptoms (AIMSS) by activation of TRPA1.

Testosterone precursor and metabolite with androgenic activity.

Testosterone precursor and metabolite with androgenic activity; may increase the risk of prostate or pancreatic cancer.

Safety Information

• Pictograms: GHS08,GHS07
• Signal Word: Danger
• Hazard Statements: H302,H351,H360FD,H362
• Precautionary Statements: P202 - P260 - P263 - P264 - P301 + P312 - P308 + P313
• Hazard Classifications: Acute Tox. 4 Oral - Carc. 2 - Lact. - Repr. 1A
• Storage Class Code: 6.1C - Combustible acute toxic Cat.3 / toxic compounds or compounds which causing chronic effects
• WGK: WGK 2